CEACAM5 and neoplasm: In order to cross-link CEA+ tumor cells with RevCAR-E7B6-armed T-cells, the bispecific anti-CEA-anti-E7B6 RevTMs must recognize CEA on tumor cells and the E7B6 epitope on RevCAR-modified T-cells.